Literature DB >> 29608192

Peeling back the onion: addressing nuances of CT screening for lung cancer.

Frank C Detterbeck1.   

Abstract

Entities:  

Year:  2018        PMID: 29608192      PMCID: PMC5864623          DOI: 10.21037/jtd.2018.01.73

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  13 in total

1.  Long-term Outcomes of Patients With Ground-Glass Opacities Detected Using CT Scanning.

Authors:  Shigeki Sawada; Natsumi Yamashita; Ryujiro Sugimoto; Tsuyoshi Ueno; Motohiro Yamashita
Journal:  Chest       Date:  2016-07-17       Impact factor: 9.410

Review 2.  The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.

Authors:  William D Travis; Hisao Asamura; Alexander A Bankier; Mary Beth Beasley; Frank Detterbeck; Douglas B Flieder; Jin Mo Goo; Heber MacMahon; David Naidich; Andrew G Nicholson; Charles A Powell; Mathias Prokop; Ramón Rami-Porta; Valerie Rusch; Paul van Schil; Yasushi Yatabe
Journal:  J Thorac Oncol       Date:  2016-04-21       Impact factor: 15.609

Review 3.  Do all lung adenocarcinomas follow a stepwise progression?

Authors:  Yasushi Yatabe; Alain C Borczuk; Charles A Powell
Journal:  Lung Cancer       Date:  2011-06-25       Impact factor: 5.705

4.  Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.

Authors:  Yasuhiro Tsutani; Yoshihiro Miyata; Haruhiko Nakayama; Sakae Okumura; Shuji Adachi; Masahiro Yoshimura; Morihito Okada
Journal:  J Thorac Cardiovasc Surg       Date:  2011-11-20       Impact factor: 5.209

5.  Natural History of Pulmonary Subsolid Nodules: A Prospective Multicenter Study.

Authors:  Ryutaro Kakinuma; Masayuki Noguchi; Kazuto Ashizawa; Keiko Kuriyama; Akiko Miyagi Maeshima; Naoya Koizumi; Tetsuro Kondo; Haruhisa Matsuguma; Norihisa Nitta; Hironobu Ohmatsu; Jiro Okami; Hiroshi Suehisa; Taiki Yamaji; Ken Kodama; Kiyoshi Mori; Kouzo Yamada; Yoshihiro Matsuno; Sadayuki Murayama; Kiyoshi Murata
Journal:  J Thorac Oncol       Date:  2016-04-16       Impact factor: 15.609

6.  New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma.

Authors:  Naoki Yanagawa; Satoshi Shiono; Masami Abiko; Shin-ya Ogata; Toru Sato; Gen Tamura
Journal:  J Thorac Oncol       Date:  2013-05       Impact factor: 15.609

7.  The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma.

Authors:  Tomohiro Murakawa; Chihiro Konoeda; Takuya Ito; Yuta Inoue; Atsushi Sano; Kazuhiro Nagayama; Jun Nakajima
Journal:  Eur J Cardiothorac Surg       Date:  2012-10-09       Impact factor: 4.191

8.  The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.

Authors:  Yasuhiro Tsutani; Yoshihiro Miyata; Takahiro Mimae; Kei Kushitani; Yukio Takeshima; Masahiro Yoshimura; Morihito Okada
Journal:  J Thorac Cardiovasc Surg       Date:  2013-06-15       Impact factor: 5.209

9.  Clinical predictor of pre- or minimally invasive pulmonary adenocarcinoma: possibility of sub-classification of clinical T1a.

Authors:  Noriyoshi Sawabata; Ryu Kanzaki; Tetsuki Sakamoto; Hidenori Kusumoto; Toru Kimura; Takashi Nojiri; Tomohiro Kawamura; Yoshiyuki Susaki; Soichiro Funaki; Tomoyuki Nakagiri; Yasushi Shintani; Masayoshi Inoue; Masato Minami; Meinoshin Okumura
Journal:  Eur J Cardiothorac Surg       Date:  2013-07-18       Impact factor: 4.191

10.  How long should small lung lesions of ground-glass opacity be followed?

Authors:  Yoshihisa Kobayashi; Takayuki Fukui; Simon Ito; Noriyasu Usami; Shunzo Hatooka; Yasushi Yatabe; Tetsuya Mitsudomi
Journal:  J Thorac Oncol       Date:  2013-03       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.